Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr. Hoenle AG Issues FY 2012/2013 Sales, Operating Profit Guidance and FY 2013/2014, FY 2014/2015 and FY 2015/2016 Turnover Guidance Above Analysts' Estimates; to Propose FY 2012/2013 Dividend


Tuesday, 4 Dec 2012 11:34pm EST 

Dr. Hoenle AG announced that its Management Board and its Supervisory Board plan to propose to the Annual General Meeting that a dividend of EUR 0.50 per share will be paid out for the fiscal year 2012/2013. The Company also announced that for the fiscal year 2012/2013 its Management Board aims at generating sales of EUR 85 million and operating profit of EUR 12 million. Dr. Hoenle AG announced that prospects to exceed the turnover threshold of EUR 100 million in fiscal year 2013/2014, fiscal year 2014/2015 and fiscal year 2015/2016 . According to I/B/E/S Estimates, analysts on average are expecting the Company to report for the fiscal year 2012/2013 revenue of EUR 71.00 million and EBIT of EUR 7.80 million, for fiscal year 2013/14 revenue of EUR 80.20 million and for fiscal year 2014/2015 revenue of EUR 89.40 million. 

Company Quote

11.625
0.125 +1.09%
11:36am EDT